FDA approves Medtronic's Bluetooth | 合法醫療器材資訊網

2020年9月1日—The770Gisanupgraded,Bluetooth-enabledversionofMedtronic'spreviouslyapprovedMiniMed670G—allowingauser,parentorcaregiverto ...

The FDA has approved the latest automated artificial pancreas system from Medtronic, the MiniMed 770G, for adults and children with Type 1 diabetes as young as 2 years old. 

This makes the hybrid, closed-loop device—designed to adjust background insulin doses in response to frequent sensor readings, with little effort needed from the wearer—the first insulin pump of its kind to be available for children between the ages of 2 and 6, the agency said[1].

Typically the blood sugar levels of people with Type 1 diabetes must be consistently measured and regulated with insulin injections via a syringe, pen or manually operated pump.

The 770G is an upgraded, Bluetooth-enabled version of Medtronic’s previously approved MiniMed 670G—allowing a user, parent or caregiver to operate the device and trigger additional insulin doses during meals via a smartphone.

The system i...